Laviana Pharma
Beijing
About Laviana Pharma
Laviana Pharma Co., Ltd. founded in 2005 is a high-tech enterprise. It specializes in providing process and manufacture outsourcing services (CDMO) for the pharmaceutical industry. The main scope of services covers all chemistry-related aspects of process development and transformation for the innovative drug substances and products from laboratory scale to commercialized scale, including process research, process development, process optimization, pilot production and large-scale production of intermediates, API starting materials and API (active pharmaceutical ingredient) for pre-clinical, clinical trial materials and commercialized products. It also provides CMC services for IND and NDA submission of innovative developmental drug. It has three wholly-owned subsidiary, namely, Beijing laviana Pharmatech Co., Ltd., Laviana (Tianjin) Pharmatech Development Co., Ltd., and Laviana Corporation incorporated in United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 501 – 1,000
- Estimated revenue: Less than $1M
- Total funding: $97.5M
- Funding stage: Late Stage Venture
- Last round: Series C (Dec 2022)
- Website: lavianacorp.com
- Phone: +86-10-80729275
Industries & Categories
Biotechnology, Health Care, Outsourcing, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/laviana-pharma-21389 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.